Placental lesions in birth asphyxia and hypoxic ischemic syndrome

Andreea Calomfirescu-Avramescu1, Luminiţa Ceauşelu1, Mihaela Demetrian1

  • 1Filantropia Clinical Hospital, 011132 Bucharest, Romania.

Medicine International
|December 3, 2024
PubMed

Birth asphyxia is a severe condition that includes a number of potential pathways of occurrence both in utero and during childbirth. The present study aimed to identify and describe specific macroscopic and microscopic placental injuries in birth asphyxia to serve as an effective tool to stratify the potential further evolution of a newborn, as hypoxic ischemic encephalopathy can be responsible for neonatal death or severe neurological sequelae further, compromising the quality of life of the affected individual. For this purpose, an observational prospective study was conducted over a period of 3 years. A total of 62 patients diagnosed with birth asphyxia, who had a placental histopathological examination performed were enrolled in the study. The control group consisted of 69 term newborns that required neonatal intensive care for at least 3 days, in the same time period, for any other reason and that also had available placental examinations. In the present study, placental histopathological lesions identified in birth asphyxia have been classified according to the Amsterdam Criteria. Data gathered from both groups were analyzed by applying specific statistical tests for each type of variable and hypothesis. Thus, umbilical cord abnormalities were associated with hypoxic ischemic encephalopathy in a statistically significant manner when comparing the birth asphyxia group of newborns with the control group. In addition, a high statistical level of significance was identified for microscopical lesions, such as maternal and fetal vascular malperfusion and the occurrence of hypoxic ischemic syndrome when comparing the two groups (P=0.01). The macroscopic and microscopic placental examination can provide critical information for the evolution of the disease in selected newborns according to the identified lesions.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
810
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
898